Haloperidol is the Medication Used to Treat Nausea
Among the listed options, haloperidol is the only medication indicated for treating nausea and vomiting, while escitalopram and citalopram cause nausea as a side effect, and morphine is not an antiemetic.
Evidence-Based Recommendation
Haloperidol: First-Line Antiemetic
The National Comprehensive Cancer Network explicitly recommends haloperidol as a first-line dopamine receptor antagonist for persistent vomiting, alongside prochlorperazine and metoclopramide, titrated to maximum benefit and tolerance 1.
Haloperidol demonstrates rapid clinical efficacy, with 79% of palliative care patients achieving complete resolution of nausea and vomiting within 48 hours at doses of 1.5 mg/24 hours (range 0.5-5 mg), with only 3% experiencing mild side effects like constipation, dry mouth, or somnolence 2.
In emergency department settings, haloperidol (mean dose 2.5 mg intravenously) successfully treated gastrointestinal symptoms in 56.6% of patients who were discharged home, and when used as the only medication, it reduced hospital admissions by 75% (odds ratio 0.25) 3.
Haloperidol works by blocking dopamine receptors in the chemoreceptor trigger zone, making it particularly effective for nausea mediated through this pathway 4.
SSRIs Cause Nausea, Not Treat It
Escitalopram and citalopram are selective serotonin reuptake inhibitors that commonly cause nausea and vomiting as adverse effects, particularly during initial treatment or dose increases 5.
While one case report suggested escitalopram might help psychogenic nausea associated with major depression, this represents treatment of the underlying psychiatric condition rather than direct antiemetic action 6.
The standard recommendation for SSRI-induced nausea is to start at lower doses and titrate slowly to minimize gastrointestinal side effects, not to use these medications as antiemetics 5.
Morphine: Not an Antiemetic
Morphine is an opioid analgesic that can actually cause nausea and vomiting as a common side effect through stimulation of the chemoreceptor trigger zone.
Chronic opioid use was associated with increased hospital admissions in patients presenting with gastrointestinal symptoms, suggesting opioids contribute to rather than resolve nausea 3.
Clinical Algorithm for Antiemetic Selection
Start with haloperidol 1.5-2.5 mg orally or intravenously for acute nausea/vomiting 1, 2.
If vomiting persists after 48 hours, add a 5-HT3 receptor antagonist (ondansetron 8 mg 2-3 times daily) rather than replacing haloperidol, as targeting different receptor mechanisms provides synergistic benefit 1.
For refractory symptoms, consider adding olanzapine, corticosteroids, or continuous infusion antiemetics 1.
Important Safety Considerations
Monitor for extrapyramidal side effects with haloperidol, though the risk is relatively low at antiemetic doses (4.4% in one study, with only 2 cases of dystonia that resolved with treatment) 2, 3.
Haloperidol carries risks of QTc prolongation and has an FDA black box warning for tardive dyskinesia, though these risks must be balanced against the significant morbidity of uncontrolled nausea and vomiting 4.
Avoid using haloperidol in patients with suspected mechanical bowel obstruction 1.